Andrea Chen, MD, Joins The Rendon Center for Dermatology and Aesthetic Medicine in Boca Raton

BOCA RATON, Fla., July 25, 2013 /PRNewswire/ --The Rendon Center for Dermatology and Aesthetic Medicine has announced the addition of Andrea Chen, MD, to the staff starting July 1, 2013. Dr. Chen specializes in Mohs micrographic surgery for skin-cancer, and in cosmetic surgical and laser procedures.

Dr. Chen graduated Phi Beta Kappa from the University of Chicago with a degree in Biological Sciences. She obtained her MD from New York University, where she was inducted into the Alpha Omega Alpha honor society.During this period, she conducted research in melanoma at the University of Louisville and co-authored several papers.

Following an internship in internal medicine at the University of Louisville (KY), Dr. Chen completed her residency in dermatology at the University of Miami (FL), where she received an award for excellence in resident teaching, and participated in research on the healing of chronic leg wounds. Dr. Chen then completed a fellowship in Mohs micrographic surgery.

Dr. Chen is board-certified in dermatology, a Fellow of the American Academy of Dermatology and a Fellow-elect of the American College of Mohs Surgery.

* * * * *

About the Rendon Center for Dermatology and Aesthetic MedicineThe Rendon Center for Dermatology & Aesthetic Medicine inBoca Raton, Florida, was founded by Marta I. Rendon, MD, a world-renowned, board-certified dermatologist.The Rendon Center offers the full complement of dermatologic services from anti-aging treatments to skin cancer removal. Dr. Rendon and her team of highly respected dermatologists provide unparalleled aesthetic and dermatologic treatments, using cutting-edge technologies and advanced techniques to provide their patients with the best results possible. http://www.drrendon.com

Media Contact: Fern Cole: F.Cole@admcorp.com

The Rendon Center for Dermatology and Aesthetic Medicine 880 N.W. 13th St., Suite 3C Boca Raton, FL 33486-2342 Phone: (561) 750-0544 Fax: (561) 750-9873 http://www.drrendon.com

Excerpt from:
Andrea Chen, MD, Joins The Rendon Center for Dermatology and Aesthetic Medicine in Boca Raton

Rapamycin: Limited anti-aging effects

Public release date: 25-Jul-2013 [ | E-mail | Share ]

Contact: Dr. Dirk Frger presse@dzne.de 49-228-433-02260 Helmholtz Association of German Research Centres

This news release is available in German.

The findings are reported in the current issue of the "Journal of Clinical Investigation" (published online on July 25, 2013).

The body's repair mechanisms begin to fail with increasing age. As a result, signs of wear and tear appear and the risk for many diseases, including Alzheimer's disease, diabetes, cardiovascular disorders and cancer, increases. "Current efforts to develop therapies against age-related diseases target these disorders one by one," says Dr. Dan Ehninger, research group leader at the DZNE site in Bonn. "Influencing the aging process itself may be an alternative approach with the potential to yield broadly effective therapeutics against age-related diseases."

In this context, the substance rapamycin is noteworthy. Rapamycin is used in recipients of organ transplants, as it keeps the immune system in check and can consequently prevent rejection of the foreign tissue. In 2009, US scientists discovered another effect: Mice treated with rapamycin lived longer than their untreated counterparts. "Rapamycin was the first drug shown to extend maximal lifespan in a mammalian species. This study has created quite a stir," says Ehninger.

For Ehninger and his team, this finding motivated further studies: "We wanted to address if rapamycin slows down aging in mice or, alternatively, if it has an isolated effect on lifespan - without broadly modulating aging."

Not a youth elixir

Together with scientists from the Helmholtz Zentrum Mnchen and other colleagues, Ehninger's group investigated if rapamycin influences aging in mice. The results are sobering: "Our results indicate that rapamycin extends lifespan, but it has only limited effects on the aging process itself," is Ehninger's summary of the findings. "Most aging traits were not affected by rapamycin treatment. Although we did observe positive effects on some aging traits, such as memory impairments and reduced red blood cell counts, our studies showed that similar drug effects are also seen in young mice, indicating that rapamycin did not influence these measures by slowing aging, but rather via other, aging-independent, mechanisms."

The researchers believe that such aging-independent drug effects also underlie rapamycin's effect on lifespan. "We assume that the lifespan of mice is extended because rapamycin inhibits tumor formation. This is a well-known rapamycin effect, which we were able to confirm. Cancer is the leading cause of death in the relevant mouse strains" says the specialist in molecular medicine. "Rapamycin, therefore, seems to have isolated effects on specific life-limiting pathology, but lacks broad effects on aging in mice."

See the original post here:
Rapamycin: Limited anti-aging effects

Food Safety Microbiology Testing Increases 40% in 5 Years to $2.9 Billion Worldwide

Woodstock, VT (PRWEB) July 25, 2013

The food microbiology testing market is healthy and robust, driven by an increasingly global food supply and focus on safe food. According to a new report from Strategic Consulting, Inc., a leading information resource in food safety testing and industrial diagnostics, the market value of food microbiology testing will reach $2.9 billion in 2013an increase of 40%, or $832 million, in the past five years.

Food Micro, Eighth Edition: Microbiology Testing in the Global Food Industry (Food Micro8) tracks and compares test volumes, market values and methods used, and forecasts future volumes and market values through to 2018 for food microbiology testing by food producers around the world. The data is based on primary research interviews with more than 450 food producers in 19 countries, including the U.S., China and India.

Three key factors are driving increases in microbiology testing around the world. The volume of food commodities produced is growing, due mainly to increases in population. Second, the rate of food microbiology testing per unit of commodity is increasing, driven by factors such as new regulations, fear of recalls and process economics. Third, the average cost per test conducted is increasing as the overall market shifts from lower-cost, traditional food microbiology tests to newer, higher-cost test methods that are being developed to shorten the time required to get actionable results.

Over the past decade, food processing companies have made investments in plants, equipment, and training for food safety testing. The investments, and resulting improvements, are not consistent in all parts of the world, however the increasing globalization of the food supply continues to drive changes and improvements. Major foodborne outbreaks like the one in Germany in 2011, when more than 4,000 people became ill and 50 people died due to E. coli O104:H4, as well as the increased media attention paid to food safety issues, as seen recently in reports of contamination of food in China, increase the pressure on food companies and retailers to make continued investments in food safety.

Food Micro8 is based on detailed primary research with 450 food plants around the globe, including 140 interviews in the Asian countries of China, India, Vietnam, Indonesia and Thailand. According to Tom Weschler, president of Strategic Consulting, Given Asias 4.1 billion population and growing importance in the global food trade, it is clearly a critical region to understand with regard to current and forecasted food microbiology testing practices.

The Report shows that food microbiology testing is reasonably spread around the world, but testing practices within geographic regions vary significantly. Europe conducts the greatest volume of food microbiology tests at 299.4 million tests, but projects the slowest future growth in test volumes and market value. Asia is currently responsible for just 29.0% of total test volume, but has the greatest potential for growth, particularly in pathogen testing.

Food Micro8 provides detailed breakdowns by microorganisms, food segments (meat, dairy, fruit/vegetable and processed foods) and geographic regions, and summarizes key trends and concerns in food microbiology testing. The data is based on primary research interviews with more than 450 food producers in 19 countries, including the U.S., China and India. An appendix with profiles of 17 of the primary diagnostic companies in the food microbiology testing market is included.

To download a detailed prospectus for Food Micro, Eighth Edition: Microbiology Testing in the Global Food Industry (Food Micro8) visit http://www.Strategic-Consult.com.

About Strategic Consulting, Inc.

Continue reading here:
Food Safety Microbiology Testing Increases 40% in 5 Years to $2.9 Billion Worldwide

T.A. Sciences Talks TA-65® Anti Aging Tech at American Academy in California

T.A. Sciences. (PRNewsFoto/T.A. Sciences)

LOS ANGELES, July 24, 2013 /PRNewswire-iReach/ -- T.A. Sciences participated at the American Academy of Anti Aging in San Diego on Saturday the 8th of June, discussing the benefits of their groundbreaking anti-cellular aging technology, TA-65. This anti-cellular aging technology is a unique molecular treatment that specifically targets the telomeres at the ends of DNA strands. TA-65 accomplishes this through cellular rejuvenation through telomerase activation.

(Logo: http://photos.prnewswire.com/prnh/20130724/MN52150)

T.A. Sciences is proud to state, since 2005, TA-65 is a proven safe product with over 10,000 users. As a proven telomerase activator, TA-65 is given to clients as part of their daily health regimen. TA-65 galvanizes the hTERT gene and triggers the activation of the enzyme telomerase, which can rejuvenate cellular aging cells.

Telomerase, the naturally-occurring enzyme that is triggered by the TA-65 product, is a vital factor in cellular health. Telomerase acts on chromosomes by protecting chromosomal DNA through sustaining their protective telomeres. Controlled activation of telomerase in normal cells can improve telomere functional capacity, increase telomere length, and actively promote an increase in cellular lifespan. T.A. Sciences tested TA-65 through rigorous research by independent third-party laboratories, and the brand follows strict scientific procedures to guarantee the efficacy and safety of their products. Participants saw a reduction in the effects of cellular aging as a result of TA-65 entering the bloodstream during an anti-cellular aging trial back in 2005.

T.A. Sciences is on the cutting edge of the new frontier known as Telomere Biology. The scientific importance of telomeres and telomerase activation in healthcare is quickly gathering momentum as some of the brightest scientific minds of both the pharmaceutical and academic world do advance research in Telomere Biology. T.A. Sciences maintains strong relationships with the leading biotech firms and opinion leaders presently in the field. Dr. Calvin Harley, who discovered the link between telomeres and cellular aging, has worked with T.A. Sciences to integrate the latest scientific findings into their products.

T.A. Sciences is the exclusive provider of the TA-65 molecule used to combat the effects of cellular aging through Telomere Biology. TA-65 is a naturally occurring molecule found within a plant root that has been used in ancient China for over a thousand years. T.A. Sciences is the only producer of this molecule that delivers such a strong and satisfactory product, a process which took years of research and over a million dollars to develop.

The proceeding information summarizes T.A. Sciences' discussion at the American Academy of Anti- Aging in San Diego.

Media Contact: T.A. Sciences, T.A. Sciences, 212.588.8805, customerservice@tasciences.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

See more here:
T.A. Sciences Talks TA-65® Anti Aging Tech at American Academy in California

Seminar deciphers significance of microbes

A national seminar on Microbes and Human Welfare organised by the Department of Microbiology, Bharathidasan University, Tiruchi, in association with National Academy of Biological Science (NABS), highlighted the role of microbes in agricultural and forestry; human and animal health, and biotechnological innovations, besides focusing on diversity and conservation of microbes.

The two-day seminar on Saturday and Sunday that was inaugurated by former Vice Chancellor of Bharathidasan University K.Meena benefitted more than 300 research scholars, PG students, and university teachers.

V.A. Parthasarathy, president of NABS and former director of Indian Institute of Spice Research, Kozhikode, presided over the inaugural session.

Sixth in its series on the theme, the workshop featured interactions involving participation of postgraduate students and young researchers. Sixty papers were orally presented and 33 through posters.

K.Ramasamy, Vice-chancellor, Tamil Nadu Agricultural University, Coimbatore, handed over the first copy of the abstract to D.P. Ray, former Vice-Chancellor, Orissa University of Agriculture and Technology, and delivered the key-note address. P.Gunaskaran, Vice-Chancellor, Thiruvalluvar University, Vellore, released news letter and books and delivered a special address.

News letter

The books and the news letter were received by K.V. Peter, director, World Noni Research Foundation.

Vice-Chancellor of Periyar University, Salem, K.Muthuchelian conferred the memorial award instituted in 2012 in the name of Prof.Kannaiyan, the founder of NABS, on Dr.Kirti Singh, chairperson, World Noni Research Foundation, Chennai. P.I. Peter, founder and chairman, Noni Biotech, Chennai, presented the NABS-Best Research Paper Award to Dr. D.Prasath of Indian Institute of Spices Research, Kozhikode.

G.Subramanian, founder director, National Facility for Marine Cyanobacteria, Bharathidasan University, Tiruchirappalli, delivered the valedictory address.

He dwelt on multidrug resistance emergence patterns, and stressed the importance of microbiology in research.

See the original post here:
Seminar deciphers significance of microbes

Natural pest control protein effective against hookworm: A billion could benefit

Public release date: 23-Jul-2013 [ | E-mail | Share ]

Contact: Jim Sliwa jsliwa@asmusa.org 202-942-9297 American Society for Microbiology

A benign crystal protein, produced naturally by bacteria and used as an organic pesticide, could be a safe, inexpensive treatment for parasitic worms in humans and provide effective relief to over a billion people around the world. Researchers from the University of California, San Diego, La Jolla, CA, report on this potentially promising solution in a study published ahead of print in the journal Applied and Environmental Microbiology.

Hookworms, and other intestinal parasites known as helminths infect more than 1 billion people in poverty-stricken, tropical nations, sucking the vitality from the body, and leaving hundreds of millions of children physically and mentally stunted. Current drugs are insufficiently effective, and resistance is rising, but little effort has been made to develop better drugs because the relevant populations do not represent a profitable market for drug companies.

"The challenge is that any cure must be very cheap, it must have the ability to be mass produced in tremendous quantities, safe, and able to withstand rough conditions, including lack of refrigeration, extreme heat, and remote locations," says Raffi Aroian, a researcher on the study.

In earlier research, Aroian and his collaborators described a protein, Cry5B, that can kill intestinal nematode parasitessuch as human hookwormsin infected test animals (hamsters). Cry5B belongs to a family of proteins that are generally accepted as safe for humans. These proteins are produced naturally in Bacillus thuringiensis (Bt), a bacterium which is applied to crops as a natural insecticide on some organic farms, and CryB proteins have been engineered into food crops such as corn and rice, to render them pest resistant.

As shown for the first time in this paper, Cry5B can also be expressed in a species of bacterium, Bacillus subtilis, which is closely related to Bacillus thuringiensis, and which is also related to bacteria which are present in some probiotics, says Aroian. In the current research researchers showed that a small dose of Cry5B, expressed in this bacterium can achieve a 93 percent elimination of hookworm parasites from infected hamsters. That, says Aroian, is substantially better than current drugs.

The scientific significance of the research, he says, is that "bacteria similar to those that are food gradewhich are cheap and can readily be mass produced--can be engineered to produce molecules that can cure parasitic diseases."

###

Aroian notes that both the Bill and Melinda Gates Foundation, and the American taxpayer, via the National Institutes of Health, played an essential role in funding the research.

Go here to read the rest:
Natural pest control protein effective against hookworm: A billion could benefit

Stem Cell Orthopedic Applauds Use of Stem Cell Therapy for Spinal Injuries

(PRWEB) July 22, 2013

The Institute of Regenerative and Molecular Orthopaedics (IRMO), world-renowned stem cell therapy experts, applauds the use of stem cell therapy for treatment of spinal injuries. In recent times, stem cell therapy has been increasingly sought after to support treatments of various injuries, especially in the sports world. Its use in repairing spinal injuries comes as good news to the thousands of Americans currently living with spinal cord injuries who are seeking the latest in breakthrough medical solutions.

Stem cell therapy is of the most exciting and promising treatments in modern medicine. Inroads are made every day, as the many applications of stem cell treatments become better understood by medical professionals around the world. Experts, like Dr. Joseph Purita of the Institute of Regenerative and Molecular Orthopaedics, have been utilizing stem cell treatments for many years to treat sports injuries.

Recent scientific and technological advancements have made stem cell extraction relatively inexpensive and accessible. Today, medical professionals have unprecedented access to these remarkable cells and are increasingly applying them in new ways to better aid in the bodys repair process. This includes advances in platelet rich plasma therapy (PRP), a process that takes a concentration of a persons own plasma and injects it into areas in need of new growth and tissue repair.

The use of stem cell therapy in the treatment of spinal cord injuries presents probably the biggest challenge yet for proponents of the treatment. Researchers are increasingly using stem cells to hopefully better understand its capabilities. The hope for spinal cord injuries is that one day stem cells can be used to generate new passageways for nerve signals to connect to muscles. The more stem cells are used for treatment in spinal cord injuries, the closer the medical field will be to fulfilling this promise.

Headed by the world-renowned stem cell treatment pioneer, Dr. Purita, the Institute of Regenerative and Molecular Orthopaedics is continually advancing the world of stem cell therapy treatments. They are one of the few orthopedic practices in existence that utilizes stem cell therapy, and PRP therapy, with orthopedic surgery to maximize a patients recovery outcome. As more stem cell treatments are being used to treat spinal injuries, Dr. Purita and his group look forward to seeing what great strides are made in battling the crippling condition in the near future.

About Stem Cell Orthopedic: The Institute of Regenerative and Molecular Orthopaedics (IRMO) is a world-class orthopedic practice and stem cell facility staffed with seasoned board certified orthopedic surgeons. They differ from most orthopedic practices because they offer stem cells and platelet rich plasma (PRP) therapy in conjunction with surgery or as alternative to surgical procedures. They utilize state-of-the-art technology and the latest in stem cell research to best treat their patients. IRMO uses hematopoietic stem cells (HSC), which are found circulating in blood, fat, and bone marrow, to help repair the body. They are headed by Medical Director, Dr. Joseph Purita, a world-renowned pioneer in laser orthopedic surgery and graduate of the esteemed Georgetown University Medical School. For more information, visit http://www.stemcellorthopedic.com/ or follow them on Facebook, Twitter, or YouTube.

More:
Stem Cell Orthopedic Applauds Use of Stem Cell Therapy for Spinal Injuries

De Leon: Medical Tourism and the Future of Stem Cell Therapy (Part 2)

LAST week, we discussed the potential of medical tourism in the country which will also provide opportunities for destinations like Baguio once tapped, and subject to competitive and international standards and government/ regulatory requirements.

So much has been written and reported about Stem Cell Therapy including its extraordinary promises that research holds for the treatment of a wide range of diseases and conditions.

This week, lets delve deeper.

What is Stem Cell Therapy?

Cell Therapy has been interchangeably called many names such as cellular therapy, fresh cell therapy, live cell therapy, glandular therapy, or xenograph or xenotransplant therapy.

The International Society for Stem Cell Research (ISSCR) describes stem cell therapy as a treatment that uses stem cells, or cells that come from stem cells, to replace or to repair a patients cells or tissues that are damaged. The stem cells might be put into the blood, or transplanted into the damaged tissue directly, or even recruited from the patients own tissues for self-repair.

Stem Cells have been differentiated based on where in the body or what stage in development they come from. ISCCR has enumerated them as follows (source:www.isscr.org):

1. Adult Stem Cells or Tissue-specific Stem Cells. Many adult tissues contain stem cells that can replace cells that die or restore tissue after injury. Skin, muscle, intestine and bone marrow, for example, each contain their own stem cells. In the bone marrow, billions of new blood cells are made every day from blood-forming stem cells. Adult stem cells are tissue-specific, meaning they are found in a given tissue in our bodies and generate the mature cell types within that particular tissue or organ. It is not clear whether all organs, such as the heart, contain stem cells. The term adult stem cells is often used very broadly and may include fetal and cord blood stem cells.

Another type of adult stem cell is the mesenchymal stem cell. These are found in a number of tissues, including bone marrow, and may be able to produce bone, cartilage and fat. It is also possible that these or similar cells may aid in the regeneration of tissues. Extensive animal studies are currently ongoing to determine if these cells may be used for treatment of diseases such as arthritis and non-healing bone fractures. It is also possible that these or similar cells modulate the immune system in response to injury.

2. Fetal Stem Cells. Fetal stem cells are taken from the fetus. The developing baby is referred to as a fetus from approximately 10 weeks of gestation. Most tissues in a fetus contain stem cells that drive the rapid growth and development of the organs. Like adult stem cells, fetal stem cells are generally tissue-specific, and generate the mature cell types within the particular tissue or organ in which they are found.

Read more:
De Leon: Medical Tourism and the Future of Stem Cell Therapy (Part 2)

Arm Anatomy | Arm bones muscles joints | Human Anatomy and Physiology video 3D animation | elearnin – Video


Arm Anatomy | Arm bones muscles joints | Human Anatomy and Physiology video 3D animation | elearnin
Understand the anatomy and physiology of Arm - the upper limb of human anatomy, its bones, joints, different arm muscles and their working.

By: elearnin

Read more here:
Arm Anatomy | Arm bones muscles joints | Human Anatomy and Physiology video 3D animation | elearnin - Video